🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHeart rate increase on GLP-1 — November 2025 Page 3

Heart rate increase on GLP-1 — November 2025

Dr.ObesityMed Thu, May 30, 2024 at 5:58 AM 31 replies 2,498 viewsPage 3 of 7
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
May 30, 2024 at 4:29 PM#11
PharmD_Rodriguez said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling, reduces NLRP3 inflammasome activation, and decreases monocyte/macrophage adhesion to endothelium[1].

Clinical correlates: hsCRP reduction of 30-60% (consistently seen across trials), reduced carotid intima-media thickness, and decreased coronary plaque inflammation on PET imaging.

These anti-inflammatory effects likely contribute to the cardiovascular benefit seen in SELECT — and may explain benefits beyond what weight loss alone would predict.

References:
[1] Hogan AE, et al. Diabetologia. 2014;57(4):781-784.
Last edited: May 30, 2024 at 8:29 PM
18 16sarah_TO, wendy_avl, jason_paloalto and 15 others
Reply Quote Save Share Report
hannah_MT
New Member
23
89
Feb 2026
Bozeman, MT
May 30, 2024 at 9:57 PM#12
Dr.LeslieOBGYN said:
Metabolic syndrome resolution on cardiovascular risk: I went from meeting 4 of 5 diagnostic criteria to meeting ZERO after 12 months of treatment.

Bookmarking. The distinction being drawn above is the one nobody else makes.

19 17MounjBrad, nick_newbie, DadBodDave and 16 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
May 31, 2024 at 3:25 AM#13
PharmD_Rodriguez said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off metoprolol entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

20 18KetoKyle, CanadaChris, ZaraB_AL and 17 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
May 31, 2024 at 8:53 AM#14
Dr.ObesityMed said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.
Dr.ObesityMed said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

21 19SandraNC_45, Dr.EndoIndy, tom_AK and 18 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 31, 2024 at 2:21 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

22 20PurityPaulOR, MaxMetOK, MounjBrad and 19 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register